Estrogen Exposure and Brain Health in Older Women

A study of 70-year-old women suggests that longer lifetime estrogen exposure, including the use of oral contraceptives and hormone therapy, is linked to better neurovascular health. Researchers found that these hormonal factors correlate with reduced cerebral small vessel disease and improved white matter integrity.
Why it matters
Understanding the neuroprotective effects of estrogen could lead to better preventative health strategies for aging women and the mitigation of cognitive decline.
GREATER lifetime estrogen exposure and hormone therapy preserve neurovascular health while reducing cerebral small vessel disease . In a population-based longitudinal investigation of 352 cognitively unimpaired 70-year-old women from the Gothenburg H70 Birth Cohort, researchers assessed how estrogen exposure and brain health are connected across the lifespan . Participants underwent comprehensive 3.0-Tesla brain MRI assessments at age 70, with a subset completing five-year follow-up scans . Women who had a longer reproductive lifespan , defined as age at menopause minus age at menarche, demonstrated significantly lower odds of high cerebral small vessel disease burden . When evaluating reproductive milestones, later age at natural menopause independently drove this vascular protection, whereas age at menarche showed no significant association .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in